» Articles » PMID: 34448147

A Wide Spectrum of Neurological Manifestations in Pediatrics Patients with the COVID-19 Infection: a Case Series

Abstract

Neurological symptoms in COVID-19 patients can also be found in the pediatric population, but they are usually described as mild symptoms. Herein, we described a case series of four pediatric patients with severe and highly heterogeneous central and peripheral nervous system manifestations. The objective was to report neurological manifestations of COVID-19 in children and adolescents. The design is case series. The participants are four children and adolescents with confirmed COVID-19. The main outcome and measures are as follows: Clinical data were gathered from electronic medical records, and data of all neurologic symptoms were checked by a trained neurologist. We reported four pediatric patients with COVID-19 and different neurologic symptoms. Case 1 was a 16-year-old girl with a sensory and motor polyradiculopathy with RT-qPCR for COVID-19 and dengue both detected in CSF that improved after appropriate treatment. Case 2 was a 15-year-old boy with Guillain-Barre syndrome and had good response after using human immunoglobulin. Case 3 was a 5-year-old girl with acute intracranial hypertension that improved after going through lumbar puncture and using acetazolamide. Case 4 was a 2-month-old male infant with focal epileptic seizures that recovered after antiepileptic treatment. We highlight the need to consider different neurologic manifestations as part of the COVID-19 clinical spectrum.

Citing Articles

Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review.

Deb N, Roy P, Biswakarma A, Mary T, Mahajan S, Khan J Pediatr Neurol. 2023; 146:65-78.

PMID: 37441883 PMC: 10195769. DOI: 10.1016/j.pediatrneurol.2023.05.011.


Pathogenesis and Preventive Tactics of Immune-Mediated Non-Pulmonary COVID-19 in Children and Beyond.

Chi H, Chang L, Chao Y, Lin D, Yang H, Fang L Int J Mol Sci. 2022; 23(22).

PMID: 36430629 PMC: 9696849. DOI: 10.3390/ijms232214157.


COVID-19 and dengue coinfection in Latin America: A systematic review.

Leon-Figueroa D, Abanto-Urbano S, Olarte-Durand M, Nunez-Lupaca J, Barboza J, Bonilla-Aldana D New Microbes New Infect. 2022; 49:101041.

PMID: 36320316 PMC: 9613782. DOI: 10.1016/j.nmni.2022.101041.


Acute COVID-19 Presenting as Neurological Disease in a Pediatric Patient.

Crowder F, Ebbert M, Neeley B, Mains N, McGuire S Clin Pediatr (Phila). 2022; 62(4):372-375.

PMID: 36171714 PMC: 10102818. DOI: 10.1177/00099228221124667.


Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping.

Zhang Y, Archie S, Ghanwatkar Y, Sharma S, Nozohouri S, Burks E Fluids Barriers CNS. 2022; 19(1):46.

PMID: 35672716 PMC: 9171490. DOI: 10.1186/s12987-022-00339-7.


References
1.
She J, Liu L, Liu W . COVID-19 epidemic: Disease characteristics in children. J Med Virol. 2020; 92(7):747-754. PMC: 7228385. DOI: 10.1002/jmv.25807. View

2.
Badat N, Abdulhussein D, Oligbu P, Ojubolamo O, Oligbu G . Risk of Transverse Myelitis Following Dengue Infection: A Systematic Review of the Literature. Pharmacy (Basel). 2018; 7(1). PMC: 6473732. DOI: 10.3390/pharmacy7010003. View

3.
Galanopoulou A, Ferastraoaru V, Correa D, Cherian K, Duberstein S, Gursky J . EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report. Epilepsia Open. 2020; 5(2):314-324. PMC: 7289172. DOI: 10.1002/epi4.12399. View

4.
Sundholm A, Burkill S, Waldenlind E, Bahmanyar S, Nilsson Remahl A . Infectious and inflammatory disorders might increase the risk of developing idiopathic intracranial hypertension - a national case-control study. Cephalalgia. 2020; 40(10):1084-1094. PMC: 7457460. DOI: 10.1177/0333102420928079. View

5.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z . Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020; 145(6). DOI: 10.1542/peds.2020-0702. View